Boehringer Ingelheim News
Most Popular Boehringer Ingelheim Story
Pharma sales undergoe major shift
Pharma sales forces have been falling under the ax a lot lately. The latest: Boehringer Ingelheim plans to halve its neurology sales force, Pharmalot reports. Some 200 reps will be affected; some may Read more...
Latest Headlines
- January 10, 2012
- January 9, 2012
- December 19, 2011
- December 8, 2011
- November 29, 2011
- November 18, 2011
- November 15, 2011
- November 14, 2011
- November 2, 2011
- November 1, 2011
- October 28, 2011
- October 20, 2011
- October 18, 2011
- September 23, 2011
- September 12, 2011
- September 9, 2011
- August 26, 2011
- August 22, 2011
- August 19, 2011
- August 17, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
